Bronchoalveolar lavage in systemic sclerosis with lung involvement: Role and correlations with functional, radiological and scintigraphic parameters

Rheumatology International

Volumn 31, Issue 9, 2011, Pages 1183-1188

  Volpinari, Stefania ^a   Corte, Renato La ^a   Bighi, Stefano ^b   Ravenna, Franco ^b   Prandini, Napoleone ^b   Monaco, Andrea Lo ^a   Trotta, Francesco ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b S ANNA HOSPITAL   (Italy)

Author keywords

Alveolar clearance; Alveolitis; Bronchoalveolar lavage; Interstitial lung disease; Lung high resolution computed tomography; Pulmonary function tests; Systemic sclerosis

Indexed keywords

CARBON MONOXIDE; CENTROMERE ANTIBODY; CYCLOPHOSPHAMIDE; DNA TOPOISOMERASE; METHYLPREDNISOLONE; PENICILLAMINE;

ADULT; ARTICLE; CAUSE OF DEATH; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; DYSPNEA; EOSINOPHIL; FEMALE; FOLLOW UP; FORCED VITAL CAPACITY; HUMAN; INTERSTITIAL LUNG DISEASE; LOW DRUG DOSE; LUNG ALVEOLITIS; LUNG DIFFUSION CAPACITY; LUNG FIBROSIS; LUNG FUNCTION TEST; LUNG LAVAGE; LUNG SCINTISCANNING; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NEUTROPHIL; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SCLERODERMA; SYSTEMIC SCLEROSIS;

ADULT; AGED; ANTIBODIES, ANTINUCLEAR; ANTIRHEUMATIC AGENTS; BRONCHOALVEOLAR LAVAGE FLUID; CENTROMERE; CYCLOPHOSPHAMIDE; DNA TOPOISOMERASES, TYPE I; FEMALE; HUMANS; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; PULMONARY FIBROSIS; RESPIRATORY FUNCTION TESTS; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX; TECHNETIUM TC 99M PENTETATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 80054943569     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-010-1390-9     Document Type: Article

References (24)

1. Steen VD, Conte C, Owens GR, Medsger TA Jr (1994) Severe restrictive lung disease in systemic sclerosis. Arthritis Rheum 37:1283-1289. doi:10.1002/art.1780370903 (Pubitemid 24320744)
2. White B, Moore WC, Wigley FM, Xiao HQ, Wise RA (2000) Cyclophosphamide is associated with pulmonary function and survival beneWt in patients with scleroderma and alveolitis. Ann Intern Med 132:947-954 (Pubitemid 30397594)
3. Baker AM, Bowton DL, Haponik EF (1995) Decision making in nosocomial pneumonia. An analytic approach to the interpretation of quantitative bronchoscopic cultures. Chest 107:85-95. doi:10. 1378/chest.107.1.85
4. Strange C, Bolster MB, Roth MD et al (2008) Bronchoalveolar la-vage and response to cyclophosphamide in scleroderma interstitial lung disease. Am J Respir Crit Care Med 177:91-98. doi:10.1164/rccm.200705-655OC
5. Subcommittee for Progressive Systemic Sclerosis (1980) Criteria of the American rheumatism association diagnostic and therapeutic criteria committee: preliminary criteria for the classiWcation of systemic sclerosis (Scleroderma). Arthritis Rheum 23:581-590. doi:10.1002/art.1780230510
6. LeRoy EC, Black C, Fleischmajer R et al (1988) Scleroderma (Systemic sclerosis): classiWcation, subset and pathogenesis. J Rheumatol 15:202-205 (Pubitemid 18073738)
7. Kahaleh MB, Sultan GL, Smith EA et al (1986) A modiWed sclero-derma skin scoring method. Clin Exp Rheumatol 4:367-369 (Pubitemid 17223177)
8. Sato S, Hamaguchi Y, Hasegawa M, Takeara K (2001) Clinical signiWcance of antitopoisomerase I antibody levels determined by ELISA in systemic sclerosis. Rheumatology 40:1135-1140. doi:10.1093/rheumatology/40.10.1135
9. Mahler DA, Weinberg DH, Wells CK, Feinstein AR (1984) The measurement of dyspnea: contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest 85:751-758. doi:10.1378/chest.85.6.751 (Pubitemid 14121920)
10. Klech H, Pohl W (1989) Technical recommendations and guidelines for bronchoalveolar lavage (BAL). Report of the European society of pneumology task group on BAL. Eur Respir J 2:561-585 (Pubitemid 19170588)
11. Behr J, Vogelmeier C, Beinert T et al (1996) Bronchoalveolar la-vage for evaluation and management of scleroderma disease of the lung. Am J Respir Crit Care Med 154:400-406 (Pubitemid 26269110)
12. The Joint statement of the ATS and ETS (2000) Idiopathic pulmonary Wbrosis: diagnosis and treatment, International Consensus Statement. Am J Respir Crit Care Med 161:646-664
13. American Thoracic Society (1995) Standardization of spirometry-1994 update. Am J Respir Crit Care Med 152:1107-1136
14. American Thoracic Society (1995) Single breath carbon monoxide diVusing capacity (transfer factor). Recommendation for a standard technique. Am J Respir Crit Care Med 152:2185-2198 Update (1995)
15. Warrick JH, Balla M, Schabel SI, Silver RM (1991) High resolution computer tomography in early scleroderma lung disease. J Rheumatol 18:1520-1528
16. Coates G, O'Brodovich H (1986) Measurement of pulmonary epithelial permeability with Tc-99 m-DTPA aerosol. Semin Nucl Med 16:275-284. doi:10.1016/S0001-2998(86)80014-9
17. Lo Monaco A, La Corte R, Prandini N et al (2005) Alveolar Clearance of 99 mTc-DTPA, Pulmonary high resolutioon CT and respiratory function tests correlations in the evaluation of lung involvement in 207 patients with systemic sclerosis. Arthritis Rheum 52(suppl):S163
18. Kon OM, Danil Z, Black CM, du Bois RM (1999) Clearance of inhaled Tc-99m-DTPA as a clinical index of pulmonary vascular disease in systemic sclerosis. Eur Respir J 13:133-136. doi:10.1183/09031936.99.13113399 (Pubitemid 29079233)
19. Diot E, Giraudeau B, Maillot F, Diot P (1999) Decrease in DLCO in systemic sclerosis correlates with acceleration of DTPA clearance. Eur Respir J 14:728-729. doi:10.1034/j.1399-3003.1999. 14c42.x (Pubitemid 29479746)
20. Wells AU, Hansell DM, Rubens MB et al (1994) Fibrosing alveo-litis in systemic sclerosis: bronchoalveolar lavage Wndings in relation to computed tomographic appearances. Am J Respir Crit Care Med 150:462-468 (Pubitemid 24252359)
21. Wells AU, Hansell DM, Haslam PL et al (1998) Bronchoalveolar lavage cellularity: lone cryptogenic Wbrosing alveolitis compared with the Wbrosing alveolitis of systemic sclerosis. Am J Respir Crit Care Med 157:1474-1482
22. Goh NSL, Veeraraghavan S, Desai SR et al (2007) Bronchoalveo-lar lavage and cellular proWles in patients with systemic sclerosis-associated interstitial lung disease are not predictive of disease progression. Arthritis Rheum 56:2005-2012. doi:10.1002/art. 22696 (Pubitemid 47110399)
23. Clements PJ, Goldin JG, Kleerup EC et al (2004) Regional diVer-ences in bronchoalveolar lavage and thoracic high-resolution computed tomography results in dyspneic patients with Systemic Sclerosis. Arthritis Rheum 50:1909-1917. doi:10.1002/art.20265 (Pubitemid 38728980)
24. Fathi N, Furst DE, Clements PJ (2007) Management of Interstitial lung disease in systemic sclerosis: lessons from SLS and FAST. Curr Rheumatol Rep 9:144-150. doi:10.1007/s11926-007-0009-y (Pubitemid 46932721)